Research Background & Mechanism
Retatrutide (triple agonist) is a GLP-1 / GIP / glucagon triple receptor agonist with a molecular weight of ~4.8 kDa. Understanding its mechanism — co-activates GLP-1, GIP and glucagon receptors in metabolic research models — matters because it defines which experimental models the peptide is suited for and which controls a lab should run.
For researchers designing a protocol, the practical takeaway is to match the peptide to a specific, testable hypothesis rather than to a broad research area. Retatrutide (triple agonist) is most consistently cited in work on triple-agonist metabolic signalling, so that is where the published literature will give you the most guidance.
Purity & Quality Standards
The baseline specification for Retatrutide should be ≥98% by HPLC with MS confirmation. High-performance liquid chromatography reports the purity percentage, while mass spectrometry confirms that the material is actually Retatrutide (triple agonist) at the expected molecular weight (~4.8 kDa) — the two checks are complementary, not redundant.
Beyond purity, verify the salt form and any residue from synthesis (such as TFA removal) on the certificate of analysis. These details are easy to overlook but can shift results in sensitive assays, so they are part of any serious supplier-verification checklist.
Storage & Handling
The correct storage condition for Retatrutide is lyophilized at -20°C. Lyophilized peptide held at this temperature keeps its stated purity far longer than material left at ambient temperature, and the difference is measurable over months of routine use.
Once reconstituted, stability drops quickly, so laboratories should refrigerate solutions and use them within the window defined by their own protocol. Plan reconstitution just before use rather than in advance.
Sourcing & Supplier Verification
A reliable Retatrutide supplier should provide a batch-specific COA showing HPLC ≥98% and an MS spectrum at ~4.8 kDa, and should be transparent about synthesis capacity and lead times. Suppliers that cannot produce these documents are the primary source of sub-standard or mis-identified material.
For bulk research purchasing, request the COA before committing to a large order, and confirm the peptide is sold strictly for laboratory and research use. A supplier that markets research peptides with therapeutic language is a red flag for compliance.
Frequently Asked Questions
Q1: How is Retatrutide priced wholesale?
Retatrutide is priced per mg with tiered discounts at higher quantities; cost per mg drops meaningfully at bulk research volumes.
Q2: Why is Retatrutide more expensive than single agonists?
Triple-agonist synthesis is more complex than a single-receptor peptide, which is reflected in a higher cost per mg.
Q3: What drives cost-per-mg differences between suppliers?
Purity (≥98% vs lower), MS verification, TFA removal, and synthesis capacity all move the price — cheap material usually means skipped QC steps.
Important: All products are sold strictly for laboratory and research purposes only — not for human or veterinary use. No medical, therapeutic, or dosing guidance is provided or implied. Researchers are responsible for compliance with their institution and local regulations.
📞 WhatsApp: +852 4419 8097 — batch-specific COA documents, bulk research pricing, and current stock for your lab.